An initial $1.35 million has been deployed to the University of California, San Francisco, to initiate the program, with additional funding announcements forthcoming.

The test detects up to 25 viral and bacterial targets, including SARS-CoV-2, influenza, Bordetella pertussis, and RSV, in one patient sample.

The firms, based in the UK and in France, are collaborating to develop an ELISA assay for a novel biomarker of severe sepsis known as oxidized pentraxin 3, or ox-PTX3.

Last week, readers were most interested in a story about Pluslife's MiniDock MTB, the only test in WHO's new class designation for tuberculosis diagnostic tests.

Labcorp said that the loan, which was provided by Wells Fargo and PNC, will be used for general corporate purposes.

Intelligenome will contribute its testing platform to an NIH-funded program centered on cell-free DNA tuberculosis detection from respiratory and blood samples.

After years of operating in the research markets, IDT has launched IVD assays based on the core chemistry capabilities from the company's Archer portfolio.

The companies will work together to develop new antibody-based technologies for pathology and other applications.

The companies intend to reduce variability and rework by aligning high-quality slide preparation with reliable digitization.

In February, the US Food and Drug Administration granted 510(k) clearance to a dozen in vitro diagnostic tests encompassing molecular, immunoassay, clinical chemistry, and ion selective electrode ...

The research team created a point-of-care assay that can detect bacterial STIs, including chlamydia and gonorrhea.